Delta Investment Management LLC Has $823,000 Stock Position in Cardinal Health, Inc. $CAH

Delta Investment Management LLC increased its position in Cardinal Health, Inc. (NYSE:CAH) by 7.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 4,898 shares of the company’s stock after purchasing an additional 356 shares during the quarter. Delta Investment Management LLC’s holdings in Cardinal Health were worth $823,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in CAH. Wellington Management Group LLP increased its position in Cardinal Health by 1,666.7% in the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock worth $328,470,000 after purchasing an additional 2,249,241 shares during the period. JPMorgan Chase & Co. boosted its holdings in Cardinal Health by 40.0% during the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock worth $575,327,000 after buying an additional 1,193,983 shares during the last quarter. Zurich Insurance Group Ltd FI boosted its holdings in Cardinal Health by 4,935.9% during the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock worth $130,434,000 after buying an additional 927,950 shares during the last quarter. Nuveen LLC bought a new position in Cardinal Health during the first quarter worth about $106,065,000. Finally, T. Rowe Price Investment Management Inc. bought a new position in Cardinal Health during the first quarter worth about $104,951,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on CAH. Leerink Partners raised their target price on Cardinal Health from $186.00 to $187.00 and gave the stock an “outperform” rating in a report on Monday, October 6th. UBS Group restated a “buy” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Evercore ISI reduced their target price on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating on the stock in a report on Wednesday, August 13th. Morgan Stanley restated an “overweight” rating on shares of Cardinal Health in a report on Tuesday, August 12th. Finally, Robert W. Baird raised their target price on Cardinal Health from $197.00 to $203.00 and gave the stock an “outperform” rating in a report on Wednesday, August 13th. Twelve research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $166.00.

Cardinal Health Price Performance

NYSE CAH opened at $161.83 on Monday. The firm has a market cap of $38.45 billion, a P/E ratio of 25.09, a P/E/G ratio of 1.37 and a beta of 0.71. The stock’s 50-day moving average is $152.75 and its 200-day moving average is $153.03. Cardinal Health, Inc. has a one year low of $106.98 and a one year high of $168.44.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Tuesday, August 12th. The company reported $2.08 EPS for the quarter, topping analysts’ consensus estimates of $2.03 by $0.05. The company had revenue of $60.16 billion for the quarter, compared to analyst estimates of $60.91 billion. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.Cardinal Health’s revenue was up .5% compared to the same quarter last year. During the same quarter last year, the firm posted $1.84 earnings per share. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. Equities analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, October 1st were paid a $0.5107 dividend. The ex-dividend date was Wednesday, October 1st. This represents a $2.04 annualized dividend and a yield of 1.3%. Cardinal Health’s payout ratio is presently 31.63%.

Insider Transactions at Cardinal Health

In other Cardinal Health news, CEO Stephen M. Mason sold 41,575 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the sale, the chief executive officer owned 26,085 shares in the company, valued at approximately $3,881,969.70. The trade was a 61.45% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Michelle D. Greene sold 13,500 shares of the business’s stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $148.82, for a total value of $2,009,070.00. Following the completion of the sale, the insider owned 14,976 shares in the company, valued at $2,228,728.32. The trade was a 47.41% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 271,676 shares of company stock worth $40,489,525. Corporate insiders own 0.12% of the company’s stock.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.